Fayez Sarofim & Co’s Sanofi SNY Stock Holding History

Fayez Sarofim & Co’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-11,180	Closed	-$559K	–	291
2022 Q2	$559K	Hold	11,180	–	–	﹤0.01%	220
2022 Q1	$574K	Hold	11,180	–	–	﹤0.01%	234
2021 Q4	$560K	Buy	+11,180	New	+$553K	﹤0.01%	250

Other funds holding SNY

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fayez Sarofim & Co's SNY Position: Q3 2022 in Review

Fayez Sarofim & Co sold out of Sanofi (SNY) in Q3 2022, closing a stake of 11,180 shares — an estimated $559K sold.

Fayez Sarofim & Co first reported a position in SNY in Q4 2021 and held it in 3 quarters. The position peaked at $574K in Q1 2022. 587 funds tracked by Wall St. Rank hold SNY as of Q3 2022.

Fayez Sarofim & Co reported no remaining Sanofi position as of Q3 2022 after selling out during the quarter.
Fayez Sarofim & Co sold 11,180 Sanofi shares in Q3 2022, an estimated $559K.
Fayez Sarofim & Co first reported a position in Sanofi in Q4 2021 and held it in 3 quarters.
Fayez Sarofim & Co's Sanofi position peaked at $574K in Q1 2022.
587 funds tracked by Wall St. Rank held Sanofi as of Q3 2022.

Based on Fayez Sarofim & Co's 13F filing for Q3 2022, filed 15 Nov 2022.